GUIDELINES OF FORCED DEGRADATION STUDIES PROTOCOL AND REPORT OF DRUG PRODUCTS ACCORDING TO RDC 53/2015
Abstract
The forced degradation study (FDS) is a key to predict the stability of an active pharmaceutical ingredient (API) isolated or in the finished product. From this, it is possible to obtain a stability indicating method by performing severe stress conditions able of to quantify all the possible degradants in the API or in the finished product. The international guidelines about this topic only give an overview on how to perform the FDS, it does not provide methodological details on a practical approach of these studies, which makes scientific standardization difficult. With the publication of RDC 53/2015 and guidelines 04/2015 by Anvisa, the international FDS practices should be revised to obtain a drug registration in Brazil. Therefore, the aim of this study is propose a template for FDS protocol and report that meets the requirements of Brazilian legislation. Degradation path, stress conditions, endpoints, percentage of degradation, mass balance, potential degradation profile, analytical validation, identification and qualification of degradation products were extensively discussed throughout this article. The model protocol and report presented complies with RDC 53/2015 in its entirety.
Keywords
Full Text:
PDF (Português (Brasil))DOI: http://dx.doi.org/10.14450/2318-9312.v30.e3.a2018.pp194-202
Refbacks
- There are currently no refbacks.
Copyright (c) 2018 Gabriel Nunes da Costa, Gil Mendes Viana, Ubiracir Fernandes Lima Filho, Lucio Mendes Cabral
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Infarma - Ciências Farmacêuticas
ISSN - 2318-9312 (Versão eletrônica)
ISSN - 0104-0219 (Versão impressa)
Conselho Federal de Farmácia - CFF
SHIS QI 15 Lote "L" - Lago Sul - Brasília - DF
CEP: 71635-615 - Fone: (61)3878-8751
e-mail:infarma@cff.org.br
Diretoria
Walter da Silva Jorge João, Presidente do Conselho Federal de Farmácia
Lenira da Silva Costa, Vice-Presidente do Conselho Federal de Farmácia
João Samuel de Morais Meira, Tesoureiro do Conselho Federal de Farmácia
Luiz Gustavo de Freitas Pires, Secretário-Geral do Conselho Federal de Farmácia